The long non‐coding RNA landscape in triple‐negative breast cancer |
| |
Authors: | Wenwen Zhang Xiaoxiang Guan Jinhai Tang |
| |
Institution: | 1. Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing China ; 2. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing China ; 3. Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing China |
| |
Abstract: | Triple‐negative breast cancer (TNBC) is a type of breast cancer that has a higher risk of distant recurrence and metastasis, leading to a relatively aggressive biological behaviour and poor outcome. So far, the clinical management of TNBC is challenging because of its heterogeneity and paucity of specific targeted therapy. Recently, various studies have identified a lot of differently expressed long non‐coding RNAs (lncRNAs) in TNBC. Those lncRNAs have been reported to play important roles in the multistep process of TNBC tumorigenesis. Here, we review the biological characteristics of lncRNAs, and present the current state of knowledge concerning the expression, function and regulation of lncRNAs in TNBC. Accumulating studies explored the potential lncRNAs‐based therapeutics in TNBC, including the techniques of genetic modification using antisense oligonucleotides, locked nucleic acid and RNA nanotechnology. In current review, we also discuss the future prospects of studies about lncRNAs in TNBC and development of lncRNA‐based strategies for clinical TNBC patients. |
| |
Keywords: | biomarkers LncRNA LncRNA‐ based therapeutics prognosis triple‐ negative breast cancer |
|
|